Shanghai Pharmaceuticals (SHA:601607, HKG:2607) proposed that its unit, Shanghai Pharmaceutical Holding, dispose of its 51% holdings in subsidiary, Shanghai Shangyao Xinte Dong'an Pharmacy, through public listing, according to a Tuesday disclosure on the Shanghai bourse.
The proposed minimum listing price is 178.5 million yuan.
Shangyao Xinte sells pharmaceuticals and operates Class III medical devices.
After the completion of the transaction, the pharmaceutical company will no longer include Shangyao Xinte in its consolidated financial statements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments